Sudeep Pharma Limited (NSE:SUDEEPPHRM)
India · Delayed Price · Currency is INR 780.50
+38.35 (5.17%)
Jun 1, 2026, 3:30 PM IST
Sudeep Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 1,729 | 1,387 | 1,332 | 623.21 | 497.99 |
Depreciation & Amortization | 148.09 | 104.99 | 89.21 | 78.29 | 47.06 |
Other Amortization | - | 0.92 | 0.92 | 0.89 | - |
Loss (Gain) From Sale of Assets | - | 0.41 | -0.02 | 0.84 | 0.03 |
Loss (Gain) From Sale of Investments | -1.21 | -0.09 | -0.94 | -0.33 | -0.51 |
Provision & Write-off of Bad Debts | 58.03 | 5.96 | -3.04 | 61.55 | 3.23 |
Other Operating Activities | -117.63 | 78 | 17.12 | 50.23 | 19.95 |
Change in Accounts Receivable | -212.9 | -406.57 | -498.91 | 79.02 | -517.42 |
Change in Inventory | -799.32 | -620.88 | 44.15 | -344.62 | -190.67 |
Change in Accounts Payable | -20.43 | 105.85 | 122.24 | 79.88 | 117.35 |
Change in Other Net Operating Assets | -88.04 | -168.61 | -445.99 | -145.01 | -3.4 |
Operating Cash Flow | 695.53 | 487.27 | 656.85 | 483.95 | -26.39 |
Operating Cash Flow Growth | 42.74% | -25.82% | 35.73% | - | - |
Capital Expenditures | -853.78 | -642.33 | -499.86 | -471.53 | -577.54 |
Sale of Property, Plant & Equipment | - | 3.4 | 0.59 | 0.4 | 0.36 |
Cash Acquisitions | -1,286 | - | - | - | - |
Sale (Purchase) of Real Estate | -327.7 | - | -24.76 | - | - |
Investment in Securities | -875.85 | -150 | 30 | -30 | 192.31 |
Other Investing Activities | 33.79 | 1.37 | 1.22 | 0.97 | 0.72 |
Investing Cash Flow | -3,309 | -787.56 | -492.8 | -500.16 | -384.15 |
Short-Term Debt Issued | 145.51 | 296.61 | 9.22 | 33.37 | 384.98 |
Long-Term Debt Issued | 70 | 380 | 10 | - | 205.38 |
Total Debt Issued | 215.51 | 676.61 | 19.22 | 33.37 | 590.36 |
Long-Term Debt Repaid | -112.6 | -95.42 | -108.97 | -84.65 | -66.44 |
Net Debt Issued (Repaid) | 102.91 | 581.19 | -89.75 | -51.28 | 523.92 |
Issuance of Common Stock | 950 | - | - | - | - |
Other Financing Activities | -180.04 | -54.23 | -37.6 | -46.49 | -18.2 |
Financing Cash Flow | 2,473 | 526.96 | -127.35 | -97.77 | 505.72 |
Foreign Exchange Rate Adjustments | 2.8 | 1.64 | 0.05 | 2.26 | - |
Miscellaneous Cash Flow Adjustments | 37.42 | - | - | - | - |
Net Cash Flow | -100.68 | 228.31 | 36.75 | -111.72 | 95.18 |
Free Cash Flow | -158.25 | -155.06 | 157 | 12.42 | -603.93 |
Free Cash Flow Growth | - | - | 1164.05% | - | - |
Free Cash Flow Margin | -2.46% | -3.09% | 3.42% | 0.29% | -17.52% |
Free Cash Flow Per Share | -1.42 | -1.43 | 1.45 | 0.11 | -5.57 |
Cash Interest Paid | 113.39 | 54.23 | 37.6 | 46.49 | 18.2 |
Cash Income Tax Paid | 554.74 | 405.5 | 447.47 | 224.2 | 175.44 |
Levered Free Cash Flow | -742.82 | -493.92 | -161.13 | -168.82 | - |
Unlevered Free Cash Flow | -695.29 | -459.8 | -137.26 | -140.18 | - |
Change in Working Capital | -1,121 | -1,090 | -778.51 | -330.73 | -594.14 |